Real-world outcomes of teriflunomide in relapsing–remitting multiple sclerosis: a prospective cohort study

OBJECTIVES: To explore efficacy, risk factors, safety, and persistence of teriflunomide in relapsing–remitting multiple sclerosis (RRMS) cohort. METHODS: This prospective, observational cohort study included 217 consecutive teriflunomide treated RRMS patients, 192 of which with at least 3-month pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yao, Yin, Hexiang, Zhang, Dingding, Xu, Yan, Peng, Bin, Cui, Liying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995164/
https://www.ncbi.nlm.nih.gov/pubmed/35403875
http://dx.doi.org/10.1007/s00415-022-11118-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995164/
https://www.ncbi.nlm.nih.gov/pubmed/35403875
http://dx.doi.org/10.1007/s00415-022-11118-7

Ejemplares similares